Form 483

Mclaughlin Gormley King Company Form 483, 2021-12-08

FDA issued a Form 483 to Mclaughlin Gormley King Company on 2021-12-08 with 2 public-safe observations.

483· Form 483 issuedHuman Drugs2 observations

Mclaughlin Gormley King Company · Chaska, United States · Issued December 8, 2021

Overview

  • 2 public-safe observations are available for this inspection.
  • 2 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

8 Dec 2021
21 CFR 211.67(b)

Written procedures not established/followed

Cited by Ross J Grigsby, Kevin P Regan

8 Dec 2021
21 CFR 211.80(a)

Written Procedures Not Followed

Cited by Ross J Grigsby, Kevin P Regan

Inspected site

MGMclaughlin Gormley King CompanyChaska, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x
21 CFR 211.80(a)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 2 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere